You heard about sema tirz and reta well... a NEW compound just dropped!

[BOGGED]

The first fat loss medication was semaglutide with was a single incretin targeting the GLP-1 receptor. Then Tirzepitide dropped shortly after with dual incretin GIP receptor as well as GLP-1. Then the gold standard was reta which was a triple incretin meaning it was hitting the GLP-1, GIP and Glucagon receptor.

Welcome The Next generation BIOGLUTIDE

This new drug targets all 3 receptors as well as a fourth something all peptide enjoyers are familiar with: the IGF-1 receptor. Anyone who has taken GH knows that GH is measured using IGF-1 while there is a separate compound called IGF-1 which is also used. This is another signaling pathway for your digestive system and is also directly responsible for muscle skeletal and fat mass.

Here is a person after taking GH:

What does this mean?

Well not much you can take reta as well as IGF-1 and achieve the same results since that covers all pathways

Spoiler: Spoiler

If you are over 15% bodyfat in the year 2025 you need to kys

 

[ru58841]

imma have to look into this, bookmarked doe

 

[LuhManiac]

dmn never heard about this thx

 

[flambria]

The first fat loss medication was semaglutide with was a single incretin targeting the GLP-1 receptor. Then Tirzepitide dropped shortly after with dual incretin GIP receptor as well as GLP-1. Then the gold standard was reta which was a triple incretin meaning it was hitting the GLP-1, GIP and Glucagon receptor.
View attachment 4019935

Welcome The Next generation BIOGLUTIDE

This new drug targets all 3 receptors as well as a fourth something all peptide enjoyers are familiar with: the IGF-1 receptor. Anyone who has taken GH knows that GH is measured using IGF-1 while there is a separate compound called IGF-1 which is also used. This is another signaling pathway for your digestive system and is also directly responsible for muscle skeletal and fat mass.

Here is a person after taking GH:
View attachment 4019941
View attachment 4019942

What does this mean?

Well not much you can take reta as well as IGF-1 and achieve the same results since that covers all pathways

Spoiler: Spoiler

If you are over 15% bodyfat in the year 2025 you need to kys

Love Big Pharma innovating

@chadisbeingmade @SlayerJonas thoughts
Might be better than Reta

I'll have to look into this compound

Imagine BIOGLUTIDE + BAM15

 

[FutureExoticChad]

Mirin a khoya

 

[LuhManiac]

Love Big Pharma innovating

@chadisbeingmade @SlayerJonas thoughts
Might be better than Reta

I'll have to look into this compound

Imagine BIOGLUTIDE + BAM15

its an Oral thats crazy

 

[flambria]

The first fat loss medication was semaglutide with was a single incretin targeting the GLP-1 receptor. Then Tirzepitide dropped shortly after with dual incretin GIP receptor as well as GLP-1. Then the gold standard was reta which was a triple incretin meaning it was hitting the GLP-1, GIP and Glucagon receptor.
View attachment 4019935

Welcome The Next generation BIOGLUTIDE

This new drug targets all 3 receptors as well as a fourth something all peptide enjoyers are familiar with: the IGF-1 receptor. Anyone who has taken GH knows that GH is measured using IGF-1 while there is a separate compound called IGF-1 which is also used. This is another signaling pathway for your digestive system and is also directly responsible for muscle skeletal and fat mass.

Here is a person after taking GH:
View attachment 4019941
View attachment 4019942

What does this mean?

Well not much you can take reta as well as IGF-1 and achieve the same results since that covers all pathways

Spoiler: Spoiler

If you are over 15% bodyfat in the year 2025 you need to kys

It is a quadruple receptor agonist, meaning it targets GLP-1, GIP, glucagon, IGF-1 receptor. Hopefully the receptor response is strong from this compound, which means it can beat Reta.

As for clinical trials, it is undergoing to evaluate the compound. Biomed Industries, Inc is the pharma company in the development of this compound.

More about the compound here: https://fitscience.co/peptides/bioglutide-na-931-info-dosage-half-life/
Talks about half-life of the compound

Mechanism of action for the compound

What is the mechanism of action of NA-931?

Introduction to NA-931 NA-931 is a novel small-molecule drug developed by Biomed SA in the field of endocrinology and metabolic diseases. Over recen

synapse.patsnap.com

"So one potential problems is that it’s a small molecule. Small molecules are great and they’re probably the future for common GLP-1 medicines (see orforglipron), but they have their own issues. One of those issues is that they’re more prone to off-target effects. It’s much easier to design a peptide that efficiently hits your targeted receptors. With a small molecule it’s more difficult to avoid hitting receptors you weren’t meaning to hit. That’s why small molecule drugs often prefer to target a single receptor, the limited scope of what the drug is trying to do makes it easier to achieve. Bioglutide is trying to target not one, not two, not three, but four different receptors all at the same time. That’s a good way to end up with a drug with a lot of off-target effects. This is the sort of issue that could derail a drug candidate like this."


"One other interesting bit, to kinda illustrate the issue of off-target effects. When Bioglutide was originally announced it wasn’t a quadruple agonist. It was a triple agonist: GLP-1/GIP/IGF-1. It wasn’t supposed to target glucagon receptors. But it’s a small molecule drug and it had an off-target effect on glucagon."

"Luckily for them glucagon is another hyped target so they just rolled with it and said it’s now a quadruple agonist. But the question you should ask is how much other stuff is it also hitting that they aren’t talking about?"

"Because Bioglutide is not a generic name unlike all of the other drug names that end in -tide. It’s a brand name pretending to be a generic name."

"It’s one of the reasons I feel something is off about this company."

@SlayerJonas @imontheloose @Zagro @chadisbeingmade

 

[flambria]

its an Oral thats crazy

Injectable will be more effective most likely, plus most consumers are already used to injecting from Ozempic. I don't see why they don't just stick to injection method.

Unless they make it very bioavailable orally, which would be a major breakthrough.

 

[LuhManiac]

Injectable will be more effective most likely, plus most consumers are already used to injecting from Ozempic.

Unless they make it very bioavailable, which would be a major breakthrough.

Yeah that what i thought too. Could be very toxic

 

[flambria]

The first fat loss medication was semaglutide with was a single incretin targeting the GLP-1 receptor. Then Tirzepitide dropped shortly after with dual incretin GIP receptor as well as GLP-1. Then the gold standard was reta which was a triple incretin meaning it was hitting the GLP-1, GIP and Glucagon receptor.
View attachment 4019935

Welcome The Next generation BIOGLUTIDE

This new drug targets all 3 receptors as well as a fourth something all peptide enjoyers are familiar with: the IGF-1 receptor. Anyone who has taken GH knows that GH is measured using IGF-1 while there is a separate compound called IGF-1 which is also used. This is another signaling pathway for your digestive system and is also directly responsible for muscle skeletal and fat mass.

Here is a person after taking GH:
View attachment 4019941
View attachment 4019942

What does this mean?

Well not much you can take reta as well as IGF-1 and achieve the same results since that covers all pathways

Spoiler: Spoiler

If you are over 15% bodyfat in the year 2025 you need to kys

Retatrutide + HGH (or HGH fragment 176-191) could likely yield more effects than Bioglutide alone, but this is not confirmed yet.

You could also pair it with DNP or the better variant BAM15.

It is a battle between: Retatrutide + HGH (or HGH fragment 176-191) + BAM15/DNP and a more simplified stack of Bioglutide + BAM15/DNP

 

[BOGGED]

Retatrutide + HGH (or HGH fragment 176-191) could likely yield more effects than Bioglutide alone, but this is not confirmed yet.

You could also pair it with DNP or the better variant BAM15.

It is a battle between: Retatrutide + HGH (or HGH fragment 176-191) + BAM15/DNP and a more simplified stack of Bioglutide + BAM15/DNP

using ratpoison aka DNP is retarded. Just use clen